From: Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population
Polymorphisms | Cases n % | Controls n % | Pa | OR (95% CI)a | Pa |
---|---|---|---|---|---|
rs67311347 | |||||
GG (ref) | 29 (33.33%) | 49 (42.98%) | |||
GA | 44 (50.57%) | 57 (50.00%) | 0.08 | 1.30 (0.71–2.38) | 0.44 |
AA | 14 (16.09%) | 8 (7.02%) | 2.95 (1.10–7.89) | 0.03 | |
G allele (ref) | 102 (58.62%) | 155 (67.98%) | |||
A allele | 72 (41.38%) | 73 (32.02%) | 1.49 (0.99–2.25) | 0.05 | |
ATM rs1800057 | |||||
CC (ref) | 80 (91.95%) | 113 (99.00%) | |||
CG | 6 (6.90%) | 1 (0.88%) | 0.03 | 8.47 (1.00–71.76) | 0.04 |
GG | 1 (1.15%) | 0 (0.00%) | Inf (Inf–Inf) | 0.41 | |
C allele (ref) | 166 (95.40%) | 227 (100.00%) | |||
G allele | 8 (4.60%) | 1 (0.44%) | 10.93 (1.35–88.31) | 0.01 | |
ALDH9A1 rs3845536 | |||||
CC (ref) | 35 (40.23%) | 36 (32.43%) | |||
CT | 46 (52.87%) | 51 (45.95%) | 0.01 | 0.92 (0.50–1.71) | 0.87 |
TT | 6 (6.90%) | 24 (21.62%) | 0.25 (0.09–0.70 | 0.007 | |
C allele | 116 (66.67%) | 123 (55.41%) | |||
T allele | 58 (33.33%) | 99 (44.59%) | 0.62 (0.41–0.93) | 0.02 |